CIMDUO
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
49502-450 -
Package NDC
49502-450-93 -
Application number
NDA022141 -
SPL ID
e63f53ae-04f8-4bbc-afa1-c62078f09855 -
SPL set ID
a300f04d-118f-4136-aaf3-ddfd00197f86 -
UNII
2T8Q726O95 -
UNII
OTT9J7900I -
RxCUI
2003249 -
RxCUI
2003255
What the source publishes
- Labeler
- Viatris Specialty LLC
- Active ingredients
- Lamivudine and Tenofovir Disoproxil Fumarate
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CIMDUO",
"splId": "e63f53ae-04f8-4bbc-afa1-c62078f09855",
"labels": [
{
"setId": "a300f04d-118f-4136-aaf3-ddfd00197f86",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a300f04d-118f-4136-aaf3-ddfd00197f86",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a300f04d-118f-4136-aaf3-ddfd00197f86"
}
],
"routes": [
"ORAL"
],
"labeler": "Viatris Specialty LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 BOTTLE, PLASTIC in 1 CARTON (49502-450-93) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC",
"package_ndc": "49502-450-93",
"identifierStatus": "well-formed",
"marketing_start_date": "20180625"
}
],
"productId": "49502-450_e63f53ae-04f8-4bbc-afa1-c62078f09855",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "49502-450",
"deaSchedule": null,
"genericName": "Lamivudine and Tenofovir Disoproxil Fumarate",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LAMIVUDINE",
"strength": "300 mg/1"
},
{
"name": "TENOFOVIR DISOPROXIL FUMARATE",
"strength": "300 mg/1"
}
],
"applicationNumber": "NDA022141",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180625",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175656",
"N0000175462",
"N0000009947"
],
"unii": [
"2T8Q726O95",
"OTT9J7900I"
],
"rxcui": [
"2003249",
"2003255"
],
"spl_set_id": [
"a300f04d-118f-4136-aaf3-ddfd00197f86"
],
"pharm_class_epc": [
"Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
"Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
],
"pharm_class_moa": [
"Nucleoside Reverse Transcriptase Inhibitors [MoA]"
],
"manufacturer_name": [
"Viatris Specialty LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:49502-450_e63f53ae-04f8-4bbc-afa1-c62078f09855"